The device joins a portfolio of vascular technologies that generated 9.5% sales growth on a comparable basis in the first quarter.
Abbott gets FDA nod, CE mark for AI-enabled imaging device
The device joins a portfolio of vascular technologies that generated 9.5% sales growth on a comparable basis in the first quarter.